If you are following Replimune Group (REPL) right now, you’re not alone. The company’s recent announcement about completing a Type A meeting with the FDA on its lead drug candidate, RP1, has put it ...

Replimune Group’s REPL share price tumbled 54.2% over the past three months. The massive setback was observed after the FDA issued a complete response letter (CRL) in July, against the biologics ...

In case you've faced some hurdles solving the clue, Class with makeup tutorials?, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, ...

Nuno will take charge of his new side for the first time at Hill Dickinson Stadium after replacing Graham Potter on Saturday. The former Nottingham Forest boss has penned a three-year deal with the ...

A MURDER probe has been launched after a man died in Aidrie and his brother was rushed to hospital. Mercy crews rushed to the town’s Hamilton Drive in the early hours of yesterday morning. Officers ...

While AI coding startups like Cursor raise brow-raising rounds on barely three years of existence, Replit's path to a $3 billion valuation has been anything but swift.

A resource for reactor physicists and engineers and students of nuclear power engineering, this publication provides a comprehensive summary of the thermophysical properties data needed in nuclear ...

From how to French brain or play the guitar to how to unclog a sing or perform CPR, you can learn all kinds of useful skills on YouTube. We at Mental Floss are always eager to learn new things and ...

Let's talk about that graveyard of old phones you have stashed in a drawer. Instead of letting them collect dust until they become ancient artifacts, it's time to put one of them to work as part of ...

Just like Joni Mitchell said, we don’t know what we’ve got until it’s gone — and that goes for the miracle that is a properly working clothes dryer. Tim Smith of Chimney Sweeps of America is an ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...